pentobarbital will decrease the extent or impact of vinorelbine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
pentobarbital will minimize the level or result of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lower the extent or impact of lumacaftor/ivacaftor by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will decrease the extent or impact of docetaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.
pentobarbital will lower the extent or impact of rolapitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Very long-phrase coadministration of powerful CYP3A4 inducers with rolapitant may noticeably lessen rolapitant efficacy.
pentobarbital will decrease the level or outcome of cortisone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lower the extent or outcome of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the extent or outcome of zonisamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.
pentobarbital will lessen the extent or result of lorlatinib by impacting hepatic/intestinal what type of drug is nembutal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or result of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
Contraindicated (1)pentobarbital decreases levels of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Potent CYP3A4 inducers can lower panobinostat stages by ~70% and lead to therapy failure.
pentobarbital will lower the level or effect of dapsone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
"Inside a sensible sense it would make little or no variance, as a result of increasing desire if you prefer, of the growing or expanding number of aged people who are demanding Manage over the end of their very own lifestyle," he said.
Contraindicated (one)pentobarbital will lower the level or result of cobimetinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Steer clear of coadministration. Robust or moderate CYP3A inducers may minimize cobimetinib systemic exposure by >80% and lower its efficacy.